COVID-19: a priority for LIH and IBBL

A dedicated webpage on the priority activities for the two institutes is now available on the LIH website

LIH and IBBL are closely collaborating with all national healthcare providers and the government in order to contain the current COVID-19 pandemic. Jointly with the Health Directorate of the Luxembourg Ministry of Health and key players in the clinical and biomedical research ecosystem, a variety of priority activities have been identified, leveraging on the cross-sectoral expertise of Research Luxembourg in molecular biology, epidemiology, clinical trials and fundamental research.

To follow the latest news and developments from LIH and Research Luxembourg — a joint initiative of the main players in Luxembourg’s public research sector— a COVID-19 webpage has been created on the LIH website. It can be accessed here.